The Indian equity markets witnessed a sharp correction on Friday, 27 March 2026, as the Nifty 50 plunged nearly 450 points (1.93%) to close around 22,856, while the Sensex tanked more than 1,500 points. According to reports from MarketSmith India, the sell-off was primarily driven by escalating US-Iran geopolitical tensions and a spike in Brent crude prices toward $123 per barrel. The market sentiment was further dampened by the Indian rupee breaching the 94 per USD mark and the government's sudden mandate for an export tax on fuels. This led to significant drag on heavyweights, with Reliance Industries sliding more than 4%. The correction was broad-based, reflected in weak market breadth with decliners (2,814) significantly outpacing advancers (505), indicating widespread pressure across segments.
Aurobindo Pharma Ltd is recommended as a buy at current price of ₹1,304.40 with a target price of ₹1,425 in two to three months. As reported by MarketSmith India, the recommendation is based on the company's strong presence in the US generics market, diversified product portfolio, robust R&D capabilities, improving margins and cost control, growth in the speciality and injectables segment, healthy balance sheet, consistent revenue growth, and expanding global footprint. The stock has a P/E ratio of 21.34 and 52-week high of ₹1,330.00, with technical analysis showing a cup-base breakout pattern. The recommended buy range is ₹1,300-1,320 with a stop loss at ₹1,240. According to Choice Broking's Hitesh Tailor, the stock is showing sustained strength after a sideways range breakout, with the price holding firmly above the breakout zone and recent support near ₹1,265 aligned with the 20-day EMA.
NLC India Ltd is recommended as a buy at current price of ₹268.60 with target prices of ₹288 and ₹296 in two to three months. According to MarketSmith India, the recommendation is supported by the company's government-owned status with strong backing, integrated power and mining business, consistent profitability track record, expansion into renewable energy, large capex growth plans, stable cash flows due to utility nature, and strategic importance in the energy sector. The stock has a P/E ratio of 13.46 and 52-week high of ₹292.20, with technical analysis showing it has reclaimed its 21-DMA. As reported by Choice Broking's Hitesh Tailor, the stock remains bullish after a symmetrical triangle breakout, with the post-breakout consolidation adding strength to the setup and clear series of higher lows indicating accumulation rather than distribution.
The market correction was reflected in overwhelmingly bearish market breadth, with nearly 473 stocks hitting 52-week lows on the NSE as reported by MarketSmith India. PSU Banks and Auto sectors were the worst laggards, with the former cratering over 3%, while IT and Pharma showed relative resilience as defensive plays. The Nifty 50 continues to exhibit a pronounced downtrend, with recent price action confirming sustained selling pressure and a breakdown below key moving averages. Immediate support for the Nifty 50 is placed near 22,600-22,400, with resistance seen around 23,500 and 23,900. According to MarketSmith India's analysis, the Indian equity market has transitioned from a 'Downtrend' to a 'Rally Attempt' with momentum indicators remaining firmly negative. The market benchmark Nifty 50 dropped more than 11% in March, wrapping the financial year 2025-26 (FY26) with a loss of 5%, marking its weakest performance since the COVID-hit FY20.
